ir.checkpointtx.comInvestor Relations :: Checkpoint Therapeutics, Inc. (CKPT)
ir.checkpointtx.com Profile
Ir.checkpointtx.com is a subdomain of checkpointtx.com, which was created on 2015-08-20,making it 9 years ago.
Description：Checkpoint Therapeutics is committed to advancing the development of cancer immunotherapy and targeted oncology treatments and creating accessible, effective and potentially more affordable options...
Discover ir.checkpointtx.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
ir.checkpointtx.com Information
| HomePage size: 30.095 KB |
| Page Load Time: 0.671271 Seconds |
| Website IP Address: 50.18.211.61 |
ir.checkpointtx.com Similar Website
| Masonite International Corp. - Investor Relations - Investor Relations |
| Block, Inc. (SQ) Investor Relations - Investor Relations |
| Gen Investor Relations - Investor Relations |
| MindChamps PreSchool Limited - Investor Relations: Investor Relations |
| Home - Ayala Land Investor Relations : Ayala Land Investor Relations |
| Universal Technical Institute's Investor Relations - UTI Investor Relations |
| Ameriprise Financial Investor Relations | Investor Relations |
| Meridian Bank Investor Relations - Meridian Bank Investor Relations |
| Armstrong World Industries Investor Relations | Armstrong Flooring Investor Relations |
| Walmart Investor Relations - Investor Relations |
| Alphabet Investor Relations - Investor Relations - Alphabet |
| Investor Relations | Jacobs - Investor Relations |
ir.checkpointtx.com PopUrls
| Investor Relations :: Checkpoint Therapeutics, Inc. (CKPT) https://ir.checkpointtx.com/ |
| Financial Results :: Checkpoint Therapeutics, Inc. (CKPT) https://ir.checkpointtx.com/financial-information/financial-results |
| Financial Information :: Checkpoint Therapeutics, Inc. (CKPT) https://ir.checkpointtx.com/financial-information |
| Press Releases :: Checkpoint Therapeutics, Inc. (CKPT) https://ir.checkpointtx.com/news-events/press-releases |
| Checkpoint Therapeutics Reports First Quarter 2024 Financial Results ... https://ir.checkpointtx.com/news-events/press-releases/detail/116/checkpoint-therapeutics-reports-first-quarter-2024 |
| SEC Filings :: Checkpoint Therapeutics, Inc. (CKPT) https://ir.checkpointtx.com/sec-filings |
| Annual Reports :: Checkpoint Therapeutics, Inc. (CKPT) https://ir.checkpointtx.com/sec-filings/annual-reports |
| Checkpoint Therapeutics Reports First Quarter 2022 Financial Results ... https://ir.checkpointtx.com/news-events/press-releases/detail/82/checkpoint-therapeutics-reports-first-quarter-2022 |
| News & Events :: Checkpoint Therapeutics, Inc. (CKPT) https://ir.checkpointtx.com/news-events |
| Checkpoint Therapeutics Announces Cosibelimab Longer-Term Results ... https://ir.checkpointtx.com/news-events/press-releases/detail/102/checkpoint-therapeutics-announces-cosibelimab-longer-term |
ir.checkpointtx.com Httpheader
| Date: Tue, 14 May 2024 13:14:35 GMT |
| Server: Apache |
| X-Frame-Options: SAMEORIGIN |
| Strict-Transport-Security: max-age=31536000; |
| X-XSS-Protection: 1; mode=block |
| X-Content-Type-Options: nosniff |
| Feature-Policy: "microphone none; camera none; geolocation none; screen-wake-lock none;", Referrer-Policy: strict-origin-when-cross-origin |
| Vary: Accept-Encoding |
| Transfer-Encoding: chunked |
| Content-Type: text/html; charset=UTF-8 |
ir.checkpointtx.com Meta Info
| content="ie=edge" http-equiv="x-ua-compatible"/ |
| charset="utf-8"/ |
| content="https://ir.checkpointtx.com" property="og:url"/ |
| content="Checkpoint Therapeutics, Inc." property="og:site_name"/ |
| content="Investor Relations" property="og:title"/ |
| content="website" property="og:type"/ |
| content="https://d1io3yog0oux5.cloudfront.net/_3a0be20af23b1a32557ab54b4843684f/checkpointtx/db/873/7006/social_image_resized.jpg" property="og:image"/ |
| content="summary_large_image" name="twitter:card"/ |
| content="initial-scale=1.0, width=device-width" name="viewport"/ |
| content="#ffffff" name="theme-color"/ |
ir.checkpointtx.com Ip Information
| Ip Country: United States |
| City Name: San Jose |
| Latitude: 37.1835 |
| Longitude: -121.7714 |
ir.checkpointtx.com Html To Plain Text
Skip to footer Back to checkpointtx.com Investor Relations Investors Overview News & Events Press Releases IR Calendar Email Alerts Company Info Management Team Presentations Contacts FAQ Financial Info Financial Results Income Statement Balance Sheet Cash Flow Stock Data Quote Charts Historical Data Analyst Coverage SEC Filings All SEC Filings Annual Reports Quarterly Reports Section 16 Filings Governance Board of Directors Board Committees Governance Documents Company Overview Checkpoint Therapeutics is committed to advancing the development of cancer immunotherapy and targeted oncology treatments and creating accessible, effective and potentially more affordable options for patients everywhere. Along with our leading candidates cosibelimab and olafertinib, we are dedicated to developing and bringing cancer therapies to market faster and actively pursuing product purchases, in-licensing and co-development opportunities that align with our areas of expertise, offering better patient outcomes and delivering significant value to the future of healthcare. Latest News View all news May 13 2024 Checkpoint Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference View Press Release May 10 2024 Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates View Press Release Mar 22 2024 Checkpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate Highlights View Press Release Stock Information Latest Financial Results Q1 2024 Quarter Ended March 31, 2024 Earnings Release PDF HTML 10-Q Filing PDF HTML XBRL ZIP XLS HTML Latest Annual Filing For Fiscal Year Ending December 31, 2023 Report Links Annual Report Document Links View 10-K Sign Up For Email Alerts Sign up today and receive company updates straight to your inbox. Sign up today IR Contacts Company Checkpoint Therapeutics, Inc. 95 Sawyer Road Suite 110 Waltham, MA 02453 T: 781-652-4500 F: 646-619-4950 info@checkpointtx.com Investor Relations LifeSci Advisors, LLC Ashley R. Robinson Managing Director T: 617-430-7577 arr@lifesciadvisors.com Transfer Agent VStock Transfer, LLC 18 Lafayette Place Woodmere, NY 11598 T: 212-828-8436 info@vstocktransfer.com https://www.vstocktransfer.com Email Alerts Contacts RSS News Feed © 2024 Checkpoint Therapeutics, Inc. All Rights Reserved. Privacy Policy Disclaimer Sitemap Market Data copyright © 2024 QuoteMedia . Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT =Real-Time, EOD =End of Day, PD =Previous Day. Market Data powered by QuoteMedia . Terms of Use...
ir.checkpointtx.com Whois
Domain Name: CHECKPOINTTX.COM Registry Domain ID: 1954222136_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2023-06-21T07:49:16Z Creation Date: 2015-08-20T17:27:45Z Registry Expiry Date: 2025-08-20T17:27:45Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: domain.operations@web.com Registrar Abuse Contact Phone: +1.8777228662 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS65.WORLDNIC.COM Name Server: NS66.WORLDNIC.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T20:10:40Z <<<